Auwaerter on Infectious Diseases

Paul G. Auwaerter, MD, MBA, has disclosed no relevant financial relationships. Dr. Auwaerter is a paid consultant to Medscape, and his participation and contributions do not constitute endorsement by The Johns Hopkins University, Hospital, or Health System.
- COVID-19 Rebound: Is Treatment Worth It?
- Hit Pandemic Show Is Fantastical but Not Baseless
- Measles in the United States: Should We Worry?
- IDWeek 2022 IDWeek 2022: COVID News for Clinical Practice or FDA Consideration
- Should I Be Immunized, and When? A COVID-19 Booster Update
- Monkeypox and HIV: Same but Different?
- COVID-19: Updates and Predictions for the Bivalent Booster
- Monkeypox Outbreak: Monitoring, Diagnosis, and Treatment
- Paxlovid Rebound: What Is Happening?
- A Surprising Cause of Abdominal Pain and Other GI Symptoms
- Is the Epstein-Barr Virus Associated With COVID-19?
- Treatment Considerations for Pregnant Women With COVID-19
- A Quick Tour of the New Lyme Disease Guideline
- COVID-19: Updated Mask Guidance From the CDC
- Monoclonals for COVID-19 a 'Minor Contribution'
- SARS-CoV-2 Diagnostics, From Serology to Spit
- 'Warning Lights' Ahead: Insights From COVID Epidemiology
- Highlights From IDWeek 2020: Fauci on COVID-19
- 'No One Is Protected' From COVID-19, Not Even the President
- This 'Slowly Evolving Crisis' Needs Attention